Validation of a sequential extraction and liquid chromatography-tandem mass spectrometric method for determination of dihydrotestosterone, androstanediol and androstanediol-glucuronide in prostate tissues

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 902, Issue , 2012, Pages 84-95

  Adomat, Hans H ^a   Bains, Onkar S ^b   Lubieniecka, Joanna M ^b   Gleave, Martin E ^a   Guns, Emma S ^a   Grigliatti, Thomas A ^b   Reid, Ronald E ^b   Riggs, K Wayne ^b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Androstanediol; Androstanediol glucuronide; Dihydrotestosterone; Fluoromethylpyridinium p toluenesulfonate derivatization; LC MS MS; Sequential extraction

Indexed keywords

ANDROSTANEDIOL; ANDROSTANEDIOL-GLUCURONIDE; DERIVATIZATIONS; DIHYDROTESTOSTERONE; LC-MS/MS; SEQUENTIAL EXTRACTION;

LIPIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; POSITIVE IONS; TISSUE; TOLUENE;

UROLOGY;

2 FLUORO 1 METHYLPYRIDINIUM PARA TOLUENE 4 SULFONATE; ACETIC ACID ETHYL ESTER; ANDROSTANEDIOL; ANDROSTANEDIOL GLUCURONIDE; ANDROSTANOLONE; GLUCURONIDE; HEXANE; STEROID; SULFONIC ACID DERIVATIVE; TOLUENE DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DERIVATIZATION; FRACTIONATION; HUMAN; HUMAN TISSUE; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

ANDROSTANE-3,17-DIOL; BENZENESULFONATES; CHROMATOGRAPHY, LIQUID; DIHYDROTESTOSTERONE; DRUG STABILITY; HUMANS; MALE; PROSTATE; PROSTATIC HYPERPLASIA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 84864104993     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.06.031     Document Type: Article

References (51)

1. Albertsen P.C. Acta Oncol. 2011, 50(Suppl. 1):120.
2. Namiki M., Akaza H., Lee S.E., Song J.M., Umbas R., Zhou L., Lee B.C., Cheng C., Chung M.K., Fukagai T., Hinotsu S., Horie S. Jpn. J. Clin. Oncol. 2010, 40(Suppl. 1):i70.
3. D'Amico F., Biancolella M., Margiotti K., Reichardt J.K., Novelli G. Pharmacogenomics 2007, 8:645.
4. Haas G.P., Delongchamps N., Brawley O.W., Wang C.Y., de la Roza G. Can. J. Urol. 2008, 15:3866.
5. American Cancer Society Inc., 2011.
6. Canadian Cancer Society, in: N.C.I.o. Canada (Ed.), 2011.
7. Gjertson C.K., Albertsen P.C. Med. Clin. North Am. 2011, 95:191.
8. LaSpina M., Haas G.P. Can. J. Urol. 2008, 15(Suppl. 1):3.
9. Risk M.C., Lin D.W. Curr. Urol. Rep. 2009, 10:179.
10. Schroder F.H. Urol. Oncol. 2010, 28:663.
11. Sumey C., Flaig T.W. Expert Opin. Pharmacother. 2011, 12:73.
12. Chu L.W., Reichardt J.K., Hsing A.W. Curr. Opin. Endocrinol. Diabetes Obes. 2008, 15:261.
13. Heinlein C.A., Chang C. Endocr. Rev. 2004, 25:276.
14. Luu-The V., Belanger A., Labrie F. Best Pract. Res. Clin. Endocrinol. Metab. 2008, 22:207.
15. Denis L.J., Griffiths K. Semin. Surg. Oncol. 2000, 18:52.
16. Bruchovsky N., Rennie P.S., Batzold F.H., Goldenberg S.L., Fletcher T., McLoughlin M.G. J. Clin. Endocrinol. Metab. 1988, 67:806.
17. Olsson M., Ekstrom L., Guillemette C., Belanger A., Rane A., Gustafsson O. Prostate 2011, 71:909.
18. Pelletier G. Best Pract. Res. Clin. Endocrinol. Metab. 2008, 22:223.
19. Thigpen A.E., Silver R.I., Guileyardo J.M., Casey M.L., McConnell J.D., Russell D.W. J. Clin. Invest. 1993, 92:903.
20. Andriole G., Bruchovsky N., Chung L.W., Matsumoto A.M., Rittmaster R., Roehrborn C., Russell D., Tindall D. J. Urol. 2004, 172:1399.
21. Hsing A.W., Reichardt J.K.V., Stanczyk F.Z. Prostate 2002, 52:12.
22. Marks L.S., Mostaghel E.A., Nelson P.S. Urology 2008, 72:247.
23. Siiteri P.K., Wilson J.D. J. Clin. Invest. 1970, 49:1737.
24. Guillemette C., Belanger A. Mol. Cell. Endocrinol. 1995, 107:131.
25. Penning T.M., Byrns M.C. Ann. N.Y. Acad. Sci. 2009, 1155:33.
26. Nunlist E.H., Dozmorov I., Tang Y., Cowan R., Centola M., Lin H.K. J. Steroid Biochem. Mol. Biol. 2004, 91:157.
27. Yang Q., Titus M.A., Fung K.M., Lin H.K. J. Cell. Biochem. 2008, 104:1612.
28. Zimmerman R.A., Dozmorov I., Nunlist E.H., Tang Y., Li X., Cowan R., Centola M., Frank M.B., Culkin D.J., Lin H.K. Prostate Cancer Prostatic Dis. 2004, 7:364.
29. Negri-Cesi P., Motta M. J. Steroid Biochem. Mol. Biol. 1994, 51:89.
30. Barbier O., Belanger A. Best Pract. Res. Clin. Endocrinol. Metab. 2008, 22:259.
31. Belanger A., Pelletier G., Labrie F., Barbier O., Chouinard S. Trends Endocrinol. Metab. 2003, 14:473.
32. Chouinard S., Barbier O., Belanger A. J. Biol. Chem. 2007, 282:33466.
33. Jakobsson J., Palonek E., Lorentzon M., Ohlsson C., Rane A., Ekstrom L. Pharmacogenomics J. 2007, 7:282.
34. Hsing A.W., Stanczyk F.Z., Belanger A., Schroeder P., Chang L., Falk R.T., Fears T.R. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1004.
35. Salerno R., Moneti G., Forti G., Magini A., Natali A., Saltutti C., Di Cello V., Costantini A., Serio M. J. Androl. 1988, 9:234.
36. Taieb J., Mathian B., Millot F., Patricot M.C., Mathieu E., Queyrel N., Lacroix I., Somma-Delpero C., Boudou P. Clin. Chem. 2003, 49:1381.
37. Wang Y., Griffiths W.J. Neurochem. Int. 2008, 52:506.
38. Santa T. Biomed. Chromatogr. 2011, 25:1.
39. Higashi T., Takayama N., Kyutoku M., Shimada K., Koh E., Namiki M. Steroids 2006, 71:1007.
40. Bald E., Mazurkiewicz B. Chromatographia 1980, 13:295.
41. Nishio T., Higashi T., Funaishi A., Tanaka J., Shimada K. J. Pharm. Biomed. Anal. 2007, 44:786.
42. O'Brien Z., Post N., Brown M., Madan A., Coon T., Luo R., Kohout T.A. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2009, 877:3515.
43. Arai S., Miyashiro Y., Shibata Y., Tomaru Y., Kobayashi M., Honma S., Suzuki K. Steroids 2011, 76:301.
44. Lin Y.H., Chen C.Y., Wang G.S. Rapid Commun. Mass Spectrom. 2007, 21:1973.
45. Titus M.A., Gregory C.W., Ford O.H., Schell M.J., Maygarden S.J., Mohler J.L., Lih F.B., Tomer K.B. Clin. Cancer Res. 2005, 11:4365.
46. Montgomery R.B., Mostaghel E.A., Vessella R., Hess D.L., Kalhorn T.F., Higano C.S., True L.D., Nelson P.S. Cancer Res. 2008, 68:4447.
47. Karypidis A.H., Olsson M., Andersson S.O., Rane A., Ekstrom L. Pharmacogenomics J. 2007, 8:147.
48. Park J.Y., Tanner J.P., Sellers T.A., Huang Y., Stevens C.K., Dossett N., Shankar R.A., Zachariah B., Heysek R., Pow-Sang J. Urology 2007, 70:374.
49. Swanson C., Mellstrom D., Lorentzon M., Vandenput L., Jakobsson J., Rane A., Karlsson M., Ljunggren O., Smith U., Eriksson A.L., Belanger A., Labrie F., Ohlsson C. J. Clin. Endocrinol. Metab. 2007, 92:4878.
50. Neslund-Dudas C., Bock C.H., Monaghan K., Nock N.L., Yang J.J., Rundle A., Tang D., Rybicki B.A. Prostate 2007, 67:1654.
51. Setlur S.R., Chen C.X., Hossain R.R., Ha J.S., Van Doren V.E., Stenzel B., Steiner E., Oldridge D., Kitabayashi N., Banerjee S., Chen J.Y., Schafer G., Horninger W., Lee C., Rubin M.A., Klocker H., Demichelis F. Cancer Epidemiol. Biomarkers Prev. 2010, 19:229.